Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
UNC Lineberger Comprehensive Cancer Center
Rutgers, The State University of New Jersey
Abramson Cancer Center at Penn Medicine
Canadian Cancer Trials Group
National Institutes of Health Clinical Center (CC)
Institute of Oncology Ljubljana
Ohio State University Comprehensive Cancer Center
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Aveta Biomics, Inc.
M.D. Anderson Cancer Center
Rigshospitalet, Denmark
National Institutes of Health Clinical Center (CC)
Inhibrx Biosciences, Inc
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Nanobiotix
European Organisation for Research and Treatment of Cancer - EORTC
University of Maryland, Baltimore
Emory University
University of Michigan Rogel Cancer Center
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)
University of Birmingham
Icahn School of Medicine at Mount Sinai